CHS/SCH | 03/02/2023
The CHS Board of Directors is a skills-based board meaning it is composed of individual skills, expertise, qualifications and personal characteristics. In 2023, multiple Board of Director positions are...
James Bayford | 20/01/2023
by James Bayford – Kelowna, British Columbia “Why?” Is a question I asked myself as I laced up my running shoes before a scheduled 20 mile (32 km) training...
David Page | 30/11/2022
Last August, the European Medicines Agency (EMA) granted conditional marketing authorization to BioMarin’s Roctavian (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A in adult patients with...
David Page | 28/11/2022
Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene dezaparvovec has been given...